Kallmann Syndrome (KS) Panel
Use
The Kallmann Syndrome (KS) Panel is designed for individuals with clinical or suspected diagnoses of Kallmann syndrome. This genetic condition is characterized by hypogonadism (a condition that affects the production of hormones) and anosmia (loss of the sense of smell). The test aims to identify genetic mutations that might contribute to the development of this disorder in affected individuals.
Special Instructions
This test can be ordered using the standard test requisition form available on the PreventionGenetics website. It offers options for exome-wide CNV analysis and STAT testing, with additional potential for family-based testing, such as duo or trio analysis.
Limitations
Test limitations include the potential for false negatives, as not all genetic causes of Kallmann syndrome may be covered by the panel. Some variants may be classified as variants of uncertain significance due to incomplete scientific understanding. Interpretation is highly reliant on the quality of clinical information provided; therefore, comprehensive clinical notes or checklists are recommended for accurate results.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided